Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Diagnostic Systems buys Oxford Bio-Innovation:

This article was originally published in Clinica

Executive Summary

Webster, Texas-based Diagnostic Systems Laboratories (DSL) has bought UK company Oxford Bio-Innovation (OBI), a joint venture between Oxford Brookes University and Serotec. The venture, which was set up in 1998, develops diagnostic and research products for the measurement of Inhibin and Activin levels, which are related to male infertility, assessment of ovarian reserve, prediction and IVF outcomes and differential diagnosis of ovarian cancer. DSL is active in reproductive endocrinology and sells its products in over 80 countries worldwide. Serotec UK supplies high quality antibodies and immunological reagents for laboratory and production processing.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts